Navigation Links
Acuo Emerges in KLAS Study as Prime Example of Provider Image Archiving Interoperability
Date:8/30/2012

BLOOMINGTON, Minn., Aug. 30, 2012 /PRNewswire/ -- Acuo Technologies®, the world leader in high-performance software and services for clinical content management and data migration, announced today that KLAS recently released the results of a new study focused on enterprise imaging strategies among U.S. healthcare providers. These organizations are at various stages of addressing federal meaningful use requirements, including "getting the right image to the right place at the right time" in order to enhance quality of care, improve patient outcomes and reduce healthcare costs.

According to the study, vendor neutral archive (VNA) strategies are becoming more popular. In describing the advantage of a VNA, the report stated "a VNA's true advantage is that it is agnostic, interoperable, and in theory can more effectively manage, archive, and distribute images and clinical media regardless of vendor, device origin, or content format." Of providers interviewed by KLAS for the study, 27% indicated that a VNA would be central to their enterprise imaging strategy (selected most often by hospitals with more than 500 beds).

The KLAS report, entitled "Enterprise Imaging 2012: Provider Strategies and Insights," identified Acuo Technologies as a VNA market pioneer, saying the company "works well with a myriad of imaging vendors." An Acuo client interviewed for the study commented that "Acuo is our long-term vendor neutral archive. All of our imaging systems in the institution now use Acuo as their long-term storage." The report further elaborated that "Acuo's [Universal Clinical Platform] technology is being used in radiology for cardiac cath, echo, EKG, and radiation oncology across vendors like GE, Siemens and Philips," citing the scenario as "a prime example of what providers hope an interoperable image archive can do for them."

"Acuo's KLAS performance results are a testament to the hard work and commitment by our team over the past twelve years, assisting healthcare organizations to become proficient at accessing and controlling clinical data previously held captive in PACS archives," said Jeff Timbrook, CEO of Acuo Technologies. "Our Universal Clinical Platform is a truly PACS-independent solution that unlocks the value of provider data. It extracts rich clinical content from departmental silos so that clinical images and related content become more liquid, making them easier to move to the point of need. A PACS-agnostic archive ultimately gives healthcare organizations greater choice and flexibility when it comes to executing the best clinical, business and technology strategies that benefit patients, providers and other stakeholders."  

The report mentioned Acuo's increasing number of vendor partnerships and growing VNA mindshare in suggesting Acuo as a "viable archive option for those that do not want to solely rely on a PACS archive." Acuo strengths highlighted in the report include VNA capabilities, strength in routing, distributing and managing images, experience in PACS data migration and ability to work with multiple PACS vendors across different departments.  For more information on this report, visit www.KLASresearch.com

About Acuo Technologies

Acuo Technologies, with headquarters in Minneapolis, MN, was founded in 2000 with the objective of developing the first enterprise-wide collaborative Universal Clinical Platform (UCP) solution for medical image content, both DICOM and Non-DICOM. Today, Acuo supports implementations of UCP around the world, including locations in Africa, Australia, Europe, North America and South America. For more information on providing superior clinical content management and data migration while simplifying operations and reducing costs, visit www.acuotech.com.

DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.


'/>"/>
SOURCE Acuo Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
2. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
3. New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
4. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
5. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
6. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
7. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
8. Staffing and Performance Benchmarks for Regulatory Function Highlight New Medical Device Study
9. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
10. New In Vitro Study Data Show That Wound Dressing With Silver Kills Multidrug-Resistant Organisms
11. Unprecedented Study shows Berlin Heart device provides life-saving "bridge" for young children and babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)...   , Total ... Consumable Sales  Clinical sales grow 16% year-over-year  ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... first quarter ended March 31, 2016 and provided an ... commercial strategy. First Quarter 2016 Revenue Results ...
(Date:4/27/2016)... April 27, 2016   Zillion Group ... health technology platform, which specializes in live video ... scalable digital products, Zillion enables companies to realize ... consumers to take control of their health. ... conferencing – including one-to-one, group and webcast scheduled ...
(Date:4/27/2016)... LEXINGTON, Massachusetts , April 27, 2016 ... announces that Jeff Poulton , Chief Financial Officer, will ... in Boston, MA on Wednesday, May ... live audio webcast will be available on the Presentations and ... Subsequently, a replay of the webcast will be available on ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, ... ... integrated manufacturer and engineer of patented products, announces the Gyrociser, an exercise invention ... industry is worth $2 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
(Date:4/29/2016)... ... ... York City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert ... sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer ... jaw bones. This surgery is performed to correct the alignment of the jaw. It is ...
(Date:4/29/2016)... OR (PRWEB) , ... April 29, 2016 , ... For ... dinner as the meal to miss. That was among the many new lifestyle diet ... on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence ...
Breaking Medicine News(10 mins):